Page breadcrumb nav

VAERS Report 2136768

Case Report Section

Détails du rapport Vaer

Âge: 78 ans

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (MODERNA))

Type : Coronavirus 2019 vaccine

Fabricant: MODERNA

Lot: 094f21a


Date de réception du rapport
2022-02-24
Date à laquelle le formulaire est complèté
Date de vaccination
2021-12-16
Date d’apparition
5
Nombre de jours (date d’apparition – date de vaccination)
5
Description de l’événement indésirable

herseninfarct; this regulatory authority case was reported by a consumer and describes the occurrence of ischaemic cerebral infarction (herseninfarct) in a 78-year-old female patient who received mrna-1273 (spikevax) (batch no. 094f21a) for covid-19 vaccination. previously administered products included for product used for unknown indication: biontech/pfizer vaccin (comirnaty) covid-19 vaccin pfizer injvlst 0,3ml on 19-mar-2021, biontech/pfizer vaccin (comirnaty) covid-19 vaccin pfizer injvlst 0 and3ml on 19-apr-2021. past adverse reactions to the above products included no adverse reaction with biontech/pfizer vaccin (comirnaty) covid-19 vaccin pfizer injvlst 0,3ml, biontech/pfizer vaccin (comirnaty) covid-19 vaccin pfizer injvlst 0 and3ml. on 16-dec-2021, the patient received dose of mrna-1273 (spikevax) (unknown route) 1 dosage form. on 21-dec-2021, the patient experienced ischaemic cerebral infarction (herseninfarct) (seriousness criterion hospitalization). at the time of the report, ischaemic cerebral infarction (herseninfarct) was resolving. no concomitant medication was provided. no treatment medication was provided. company comment: this regulatory case concerns a 78-year-old female patient no reported medical history, who experienced the unexpected serious aesi event of ischaemic cerebral infarction 6 days following the receipt of mrna-1273 vaccine. the patient had previously received 2 doses of comirnaty (interchange of vaccine products). elderly age of the patient can be a risk factors for the event. the benefit-risk relationship of mrna-1273 is not affected by this report. seriousness of the event retained as per regulatory authority reporting.; sender's comments: this regulatory case concerns a 78-year-old female patient no reported medical history, who experienced the unexpected serious aesi event of ischaemic cerebral infarction 6 days following the receipt of mrna-1273 vaccine. the patient had previously received 2 doses of comirnaty (interchange of vaccine products). elderly age of the patient can be a risk factors for the event. the benefit-risk relationship of mrna-1273 is not affected by this report. seriousness of the event retained as per regulatory authority reporting

Données de laboratoire
na
Liste des symptômes
ischaemic cerebral infarction
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Unknown
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Oui
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na